14th Aug 2014 05:58
LONDON (Alliance News) - A selection of the biggest drugmakers in Europe are understood to be among the bidders for US biotechnology firm InterMune Inc, Bloomberg reported on Thursday, citing people with knowledge of the deal.
Goldman Sachs Group Inc and Centerview Partners LLC are advising InterMune on the bids. Shares in the company were up 14% in New York trade, giving the company a market value of USD5.62 billion.
GlaxoSmithKline PLC, Actelion Ltd, Sanofi SA and Roche Holding AG are all thought to be interested in acquiring firm, with the sources suggesting Sanofi is showing the most interest.
http://www.bloomberg.com/news/2014-08-13/europe-s-biggest-drugmakers-said-to-bid-for-intermune.html
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Glaxosmithkline